<DOC>
	<DOCNO>NCT00169598</DOCNO>
	<brief_summary>This randomise study aim evaluate medical economical impact positron emission tomography ( PET ) use fluorine-18-fluoro-deoxyglucose ( FDG ) therapeutic prescription patient Hodgkin ’ lymphoma large B P cell non-Hodgkin ’ lymphoma . The median progression free survival , cost quality life compare two group : Group 1 : result conventional staging PET know stem cell transplantation . Group 2 : result conventional staging stem cell transplantation know stem cell transplantation .</brief_summary>
	<brief_title>Remission Evaluation Before Intensified Treatment Lymphoma : Impact Positron Emission Tomography ( PET ) Using Fluorine-18-Floro-Deoxyglucose ( FDG ) Therapeutic Prescription . Medico-Economic Randomised Study</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Deoxyglucose</mesh_term>
	<criteria>Age 18 , Hodgkin ’ lymphoma large B P cell nonHodgkin ’ lymphoma , firstline chemotherapy least residual mass induction chemotherapy progression . Stem cell transplantation would program . Patients require give write informed consent . Progressive cancer diagnose less 5 year , except cancer situ cervix basocell skin carcinoma , kidney insufficiency diabetes . Patients would pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>stem cell transplantation</keyword>
	<keyword>therapeutic impact</keyword>
</DOC>